Clinical Trial Update: Use of Transdermal Clonidine in Trauma Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating transdermal clonidine for delirium in trauma patients was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Catapres-TTS (clonidine (transdermal patch))

Snippet

Sponsor: Memorial Health University Medical Center | Conditions: Delirium | Phase 4 | Status: TERMINATED | Results posted: 2017-06-14